Genexine, Inc. (095700.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap213.02B
Enterprise Value311.72B
P/E Ratio-5.73
PEG Ratio-0.04
Price/Sales Ratio25.18
Price/Book Ratio0.51
Enterprise/Revenue46.69
Enterprise/EBITDA21.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-4.4
Operating Margin-7.8
AD

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.08

Income Statement

Revenue4.57B
Revenue/Share102.66
Gross Profit-4.28B
EBITDA-29.04B
Net Income-27.01B
Diluted EPS-594.1

Balance Sheet

Total Cash24.21B
Total Cash/Share532.4
Total Debt104.3B
Total Debt/Equity0.45
Current Ratio0.3
Book Value Per Share5,049.61

Price History

52-Week Change-46.92
52-Week High7,490
52-Week Low2,570
Moving Average 50 Days4,502
Moving Average 200 Days4,837.13

Statistics

Average Volume551,979
Shares Outstanding45.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor13:10
Last Split DateJanuary 11, 2023
AD